Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
24 hedge funds and large institutions have $3.35M invested in Acer Therapeutics Inc in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
4% less funds holding
Funds holding: 25 → 24 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
14% less capital invested
Capital invested by funds: $3.91M → $3.35M (-$559K)
58% less call options, than puts
Call options by funds: $5K | Put options by funds: $12K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.1K |
| 2 |
Renaissance Technologies
New York
|
+$40.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$29.2K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$6.55K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$94K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$46K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$35K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$30K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | +$42 | +18 | New |
|
ACER Hedge Fund Activity: Q4 2021 in Review
24 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2021, worth a combined $3.35M — down 14% from $3.91M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ACER and 6 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $48.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $94K sold.
- 24 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2021, down from 25 in Q3 2021.
- Funds reported $3.35M of Acer Therapeutics Inc stock for Q4 2021, down 14% quarter-over-quarter.
- 6 funds opened new Acer Therapeutics Inc positions in Q4 2021 and 7 closed out, a net change of -1 holder.
- The largest Acer Therapeutics Inc buyer in Q4 2021 was Geode Capital Management, an estimated $48.1K added.
- The largest Acer Therapeutics Inc seller in Q4 2021 was Citadel Advisors, an estimated $94K sold.
Based on aggregated 13F filings for Q4 2021.